Abstract:In recent years, aggregation-induced emission (AIE)-active materials have been emerging as a promising means for bioimaging and phototherapy. However, the majority of AIE luminogens (AIEgens) need to be encapsulated into versatile nanocomposites to improve their biocompatibility and tumor targeting. Herein, we prepared a tumor- and mitochondria-targeted protein nanocage by the fusion of human H-chain ferritin (HFtn) with a tumor homing and penetrating peptide LinTT1 using genetic engineering technology. The LinTT1-HFtn could serve as a nanocarrier to encapsulate AIEgens via a simple pH-driven disassembly/reassembly process, thereby fabricating the dual-targeting AIEgen-protein nanoparticles (NPs). The as designed NPs exhibited an improved hepatoblastoma-homing property and tumor penetrating ability, which is favorable for tumor-targeted fluorescence imaging. The NPs also presented a mitochondria-targeting ability, and efficiently generated reactive oxygen species (ROS) upon visible light irradiation, making them valuable for inducing efficient mitochondrial dysfunction and intrinsic apoptosis in cancer cells. In vivo experiments demonstrated that the NPs could provide the accurate tumor imaging and dramatic tumor growth inhibition with minimal side effects. Taken together, this study presents a facile and green approach for fabrication of tumor- and mitochondria-targeted AIEgen-protein NPs, which can serve as a promising strategy for imaging-guided photodynamic cancer therapy. Statement of Significance AIE luminogens (AIEgens) show strong fluorescence and enhanced ROS generation in the aggregate state, which would facilitate the image-guided photodynamic therapy. However, the major obstacles that hinder biological applications are their lack of hydrophilicity and selective targeting. To address this issue, this study presents a facile and green approach for the fabrication of tumor‐ and mitochondria‐targeted AIEgen-protein nanoparticles via a simple disassembly/reassembly of the LinTT1 peptide-functionalized ferritin nanocage without any harmful chemicals or chemical modification. The targeting peptide-functionalized nanocage not only restricts the intramolecular motion of AIEgens leading to enhanced fluorescence and ROS production, but also confers good targeting to AIEgens.

Cellular organelle-targeted smart AIEgens in tumor detection, imaging and therapeutics

Aggregation‐induced Emission Luminogens for in Vivo Molecular Imaging and Theranostics in Cancer

Mitochondria-targeted smart AIEgens: Imaging and therapeutics

Aggregation‐induced Emission Based Fluorogens for Mitochondria‐targeted Tumor Imaging and Theranostics

Optical Molecular Imaging and Theranostics in Neurological Diseases Based on Aggregation-Induced Emission Luminogens

Recent advances in AIE-based platforms for cancer immunotherapy

A Mitochondria-targeted AIEgen Labelled with <SUP>18</SUP>F for Breast Cancer Cell Imaging and Therapy

Stimuli-responsive nanotheranostic systems conjugated with AIEgens for advanced cancer bio-imaging and treatment

AIE Luminogens for Bioimaging and Theranostics: from Organelles to Animals

AIEgens for microorganism‐related visualization and therapy

Enzyme‐Mediated Intracellular Polymerization of AIEgens for Light‐Up Tumor Localization and Theranostics

In Response to Precision Medicine: Current Subcellular Targeting Strategies for Cancer Therapy

Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology

Tandem Targeting and Dual Aggregation of an AIEgen for Enhanced Near-Infrared Fluorescence Imaging of Tumors

Precise Subcellular Organelle Targeting for Boosting Endogenous‐Stimuli‐Mediated Tumor Therapy

The Bioimaging Story of AIEgens

Intracellularly Manipulable Aggregation of the Aggregation-Induced Emission Luminogens

Visualizing intracellular dynamics with AIE probes

Donor–Acceptor–Donor Near-Infrared-II Aggregation-Induced Emission Luminogens (AIEgens) Encapsulated within Nanometer-Sized Exosomes for Tumor Imaging

Facile and green fabrication of tumor- and mitochondria-targeted AIEgen-protein nanoparticles for imaging-guided photodynamic cancer therapy

Endowing AIE with Extraordinary Potential: A New Au(I)‐Containing AIEgen for Bimodal Bioimaging‐Guided Multimodal Synergistic Cancer Therapy